Viatris Inc

NASDAQ:VTRS USA Drug Manufacturers - Specialty & Generic
Market Cap
$15.89 Billion
Market Cap Rank
#1193 Global
#917 in USA
Share Price
$13.80
Change (1 day)
+2.22%
52-Week Range
$7.26 - $16.13
All Time High
$47.92
About

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and … Read more

Viatris Inc (VTRS) - Total Assets

Latest total assets as of September 2025: $37.92 Billion USD

Based on the latest financial reports, Viatris Inc (VTRS) holds total assets worth $37.92 Billion USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Viatris Inc - Total Assets Trend (1985–2024)

This chart illustrates how Viatris Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Viatris Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Viatris Inc's total assets of $37.92 Billion consist of 22.9% current assets and 77.1% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 1.8%
Accounts Receivable $3.52 Billion 8.5%
Inventory $3.85 Billion 9.3%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $17.07 Billion 41.1%
Goodwill $9.13 Billion 22.0%

Asset Composition Trend (1985–2024)

This chart illustrates how Viatris Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Viatris Inc's current assets represent 22.9% of total assets in 2024, a decrease from 79.5% in 1985.
  • Cash Position: Cash and equivalents constituted 1.8% of total assets in 2024, down from 26.8% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, an increase from 0.0% in 1985.
  • Asset Diversification: The largest asset category is intangible assets at 41.1% of total assets.

Viatris Inc Competitors by Total Assets

Key competitors of Viatris Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Viatris Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.19 - 0.42

Lower asset utilization - Viatris Inc generates 0.36x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -2.31% - 4.16%

Negative ROA - Viatris Inc is currently not profitable relative to its asset base.

Viatris Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.35 1.51 1.22
Quick Ratio 0.79 0.96 0.70
Cash Ratio 0.00 0.00 0.00
Working Capital $2.59 Billion $ 3.80 Billion $ 2.30 Billion

Viatris Inc - Advanced Valuation Insights

This section examines the relationship between Viatris Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.19
Latest Market Cap to Assets Ratio 0.38
Asset Growth Rate (YoY) -13.0%
Total Assets $41.50 Billion
Market Capitalization $15.79 Billion USD

Valuation Analysis

Below Book Valuation: The market values Viatris Inc's assets below their book value (0.38 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Viatris Inc's assets decreased by 13.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Viatris Inc (1985–2024)

The table below shows the annual total assets of Viatris Inc from 1985 to 2024.

Year Total Assets Change
2024-12-31 $41.50 Billion -12.97%
2023-12-31 $47.69 Billion -4.67%
2022-12-31 $50.02 Billion -8.79%
2021-12-31 $54.84 Billion -10.90%
2020-12-31 $61.55 Billion +96.93%
2019-12-31 $31.26 Billion -4.52%
2018-12-31 $32.73 Billion -8.58%
2017-12-31 $35.81 Billion +3.11%
2016-12-31 $34.73 Billion +55.95%
2015-12-31 $22.27 Billion +40.75%
2014-12-31 $15.82 Billion +3.44%
2013-12-31 $15.29 Billion +28.18%
2012-12-31 $11.93 Billion +2.88%
2011-12-31 $11.60 Billion +0.53%
2010-12-31 $11.54 Billion +6.81%
2009-12-31 $10.80 Billion +3.93%
2008-12-31 $10.39 Billion -8.45%
2007-12-31 $11.35 Billion +166.89%
2006-12-31 $4.25 Billion +127.42%
2005-12-31 $1.87 Billion -12.42%
2004-12-31 $2.14 Billion +13.29%
2003-12-31 $1.89 Billion +8.01%
2002-12-31 $1.75 Billion +7.95%
2001-12-31 $1.62 Billion +10.28%
2000-12-31 $1.47 Billion +9.30%
1999-12-31 $1.34 Billion +11.15%
1998-12-31 $1.21 Billion +42.33%
1997-12-31 $847.80 Million +9.03%
1996-12-31 $777.60 Million +12.37%
1995-12-31 $692.00 Million +26.69%
1994-12-31 $546.20 Million +35.43%
1993-12-31 $403.30 Million +14.87%
1992-12-31 $351.10 Million +54.87%
1991-12-31 $226.70 Million +33.67%
1990-12-31 $169.60 Million +23.35%
1989-12-31 $137.50 Million +22.01%
1988-12-31 $112.70 Million +3.58%
1987-12-31 $108.80 Million +35.49%
1986-12-31 $80.30 Million +43.39%
1985-12-31 $56.00 Million --